The acquisition of innovative and entrepreneurial firms has become an important issue in gaining competition advantages. While there exists a fruitful and promising literature analyzing M&A activities ...
Lantern Pharma has filed IPO paperwork to raise money to test a failed cancer prospect. The drug, LP-300, failed five phase 3 trials between 2006 and 2013, but retrospective analyses of data from two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback